Literature DB >> 21166372

End-stage Renal Disease.

Maaz Abbasi1, Glenn Chertow, Yoshio Hall.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 21166372

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


× No keyword cloud information.
  5 in total

1.  Risk factors for pulmonary hypertension in maintenance hemodialysis patients: a cross-sectional study.

Authors:  Yanjun He; Yuling Wang; Xingying Luo; Jianting Ke; Yi Du; Mi Li
Journal:  Int Urol Nephrol       Date:  2015-11       Impact factor: 2.370

2.  Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan.

Authors:  Kao-Chi Cheng; Yu-Lung Chen; Shih-Wei Lai; Chih-Hsin Mou; Pang-Yao Tsai; Fung-Chang Sung
Journal:  BMC Nephrol       Date:  2012-09-29       Impact factor: 2.388

3.  Analgesia for Pediatric Arteriovenous Fistula Cannulation in Hemodialytic Patients: A Comparison of Lidocaine Gel, Lidocaine Spray, and Needle Plate.

Authors:  Yalda Ravanshad; Mohaddeseh Golsorkhi; Sahar Ravanshad; Anoush Azarfar; Mohammad Esmaeeli; Alireza Ghodsi
Journal:  Indian J Nephrol       Date:  2020-11-07

Review 4.  Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.

Authors:  Janet B McGill; Hermann Haller; Prabir Roy-Chaudhury; Andrea Cherrington; Takashi Wada; Christoph Wanner; Linong Ji; Peter Rossing
Journal:  BMJ Open Diabetes Res Care       Date:  2022-07

5.  Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.

Authors:  Rajiv Agarwal; Stefan D Anker; George Bakris; Gerasimos Filippatos; Bertram Pitt; Peter Rossing; Luis Ruilope; Martin Gebel; Peter Kolkhof; Christina Nowack; Amer Joseph
Journal:  Nephrol Dial Transplant       Date:  2022-05-25       Impact factor: 7.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.